BridgeMD
Compares treatment options for Chronic Subdural Hematoma
Official title Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma
ClinicalTrials.gov ID: NCT07144423
What this study is testing
- What it's testing
- Chronic subdural hematoma (CSDH) is a frequent condition in neurosurgery, leading to fluid accumulation between the meninges, brain compression, neurological dysfunction, and potentially herniation. The efficacy of treatments and their long-term outcomes remain uncertain, with no established standard.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Patient (18 years to 90 years) presenting with clinical symptoms and neurological deficits of CSDH.
- CSDH verified on cranial computed tomography or magnetic resonance imaging.
- Written informed consent from patients or their next of kin according to the patient's cognitive status.
You likely can't join if
- No clinical symptoms correlating with chronic subdural hematoma.
- Lack of mass effect and midline shift \< 5 mm on the radiological image, or no need surgery judged clinically by neurosurgeons.
- Previous surgery for CSDH during the past 6 months.
- Previous intracranial surgery for any other neurological disorder.
- Poor medication conditions or the presence of severe comorbidities so that surgery cannot be tolerated, or follow-up cannot be completed.
- Severe coagulopathy or a high risk of life-threatening bleeding (including any one of the following three criteria: prothrombin time or activated...
See the full eligibility criteria
- Patient (18 years to 90 years) presenting with clinical symptoms and neurological deficits of CSDH.
- CSDH verified on cranial computed tomography or magnetic resonance imaging.
- Written informed consent from patients or their next of kin according to the patient's cognitive status.
- No clinical symptoms correlating with chronic subdural hematoma.
- Lack of mass effect and midline shift \< 5 mm on the radiological image, or no need surgery judged clinically by neurosurgeons.
- Previous surgery for CSDH during the past 6 months.
- Previous intracranial surgery for any other neurological disorder.
- Poor medication conditions or the presence of severe comorbidities so that surgery cannot be tolerated, or follow-up cannot be completed.
- Severe coagulopathy or a high risk of life-threatening bleeding (including any one of the following three criteria: prothrombin time or activated partial thromboplastin time prolonged by more than 10 seconds...
- Postoperative compliance is suspected to be insufficient for 3-month follow-up visit.
- Reproductive-age women without verified negative pregnancy testing.
- Participating in another research.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
- Xiamen, Fujian, China
- Jiangmen, Guangdong, China
- Shantou, Guangdong, China
- Shenzhen, Guangdong, China
- Liuzhou, Guangxi, China
- Nanning, Guangxi, China
- Wuzhou, Guangxi, China
- Handan, Hebei, China
- Xingtai, Hebei, China
- Changde, Hunan, China
- Jishou, Hunan, China
- Yueyang, Hunan, China
- Changzhi, Shanxi, China
- Linfen, Shanxi, China
- Taiyuan, Shanxi, China
- Xi’an, Shanxi, China
- Mianyang, Sichuan, China
- Yibin, Sichuan, China
- Ürümqi, Xinjiang, China
+ 2 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China; Xiamen, Fujian, China; Jiangmen, Guangdong, China; Shantou, Guangdong, China; Shenzhen, Guangdong, China; Liuzhou, Guangxi, China and 16 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.